Stimcell Energetics (STME) Research & Development (2016 - 2023)
Stimcell Energetics' (STME) quarterly Research & Development came in at $301.0 in Q4 2023, down 98.66% year-on-year from $22407.0 in Q4 2022, and down 1.63% quarter-over-quarter from $306.0 in Q3 2023.
Stimcell Energetics (STME) Research & Development (2016 - 2023) Analysis & Trends
Stimcell Energetics' Research & Development history runs 8 years deep, the most recent figure standing at $301.0 for Q4 2023.
- On a quarterly basis, Research & Development fell 98.66% year-over-year to $301.0 in Q4 2023; TTM through Nov 2023 was $44577.0, a 65.35% decrease from a year earlier, with the FY2023 full-year figure at $89220.0, down 40.8% from the prior year.
- Research & Development fell to $301.0 in Q4 2023 per STME's latest filing, from $306.0 in the prior quarter.
- Across five years, Research & Development topped out at $127494.0 in Q2 2020 and bottomed at $301.0 in Q4 2023.
- The 5-year median for Research & Development is $37189.5 (2020), against an average of $47093.6.
- Across the five-year window, Research & Development jumped 778.84% in 2020 and sank 99.19% in 2023, its largest moves.
- Year by year, Research & Development stood at $95894.0 in 2019, then sank by 59.81% to $38538.0 in 2020, then slipped by 18.38% to $31456.0 in 2021, then dropped by 28.77% to $22407.0 in 2022, then slumped by 98.66% to $301.0 in 2023.
- Per Business Quant, the three latest STME Research & Development figures stand at $301.0 (Q4 2023), $306.0 (Q3 2023), and $424.0 (Q2 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | 301.00 |
| Aug 31, 2023 | 306.00 |
| May 31, 2023 | 424.00 |
| Feb 28, 2023 | 43,546.00 |
| Nov 30, 2022 | 22,407.00 |
| Aug 31, 2022 | 22,843.00 |
| May 31, 2022 | 52,528.00 |
| Feb 28, 2022 | 30,884.00 |
| Nov 30, 2021 | 31,456.00 |
| Aug 31, 2021 | 35,841.00 |
| May 31, 2021 | 35,761.00 |
| Feb 28, 2021 | 70,145.00 |
| Nov 30, 2020 | 38,538.00 |
| Aug 31, 2020 | 85,137.00 |
| May 31, 2020 | 127,494.00 |
| Feb 29, 2020 | 109,115.00 |
| Nov 30, 2019 | 95,894.00 |
| Aug 31, 2019 | 60,713.00 |
| May 31, 2019 | 14,507.00 |
| Feb 28, 2019 | 64,033.00 |